Cargando…
Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl
In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following subs...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186194/ https://www.ncbi.nlm.nih.gov/pubmed/37200853 http://dx.doi.org/10.2903/j.efsa.2023.8013 |
_version_ | 1785042514348081152 |
---|---|
collection | PubMed |
description | In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following substances/commodity combinations: 2,4‐DB on products of animal origin; iodosulfuron‐methyl on linseeds and maize; mesotrione on sugar canes; methoxyfenozide on aubergines and products of animal origin and pyraflufen‐ethyl on hops. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation. |
format | Online Article Text |
id | pubmed-10186194 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101861942023-05-17 Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl EFSA J Statement In accordance with Article 31 of Regulation (EC) No 178/2002, the European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 MRL reviews under Regulation (EC) No 396/2005 for the following substances/commodity combinations: 2,4‐DB on products of animal origin; iodosulfuron‐methyl on linseeds and maize; mesotrione on sugar canes; methoxyfenozide on aubergines and products of animal origin and pyraflufen‐ethyl on hops. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation. John Wiley and Sons Inc. 2023-05-16 /pmc/articles/PMC10186194/ /pubmed/37200853 http://dx.doi.org/10.2903/j.efsa.2023.8013 Text en © 2023 European Food Safety Authority. EFSA Journal published by Wiley‐VCH GmbH on behalf of European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Statement Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title | Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title_full | Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title_fullStr | Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title_full_unstemmed | Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title_short | Lack of confirmatory data following Article 12 MRL reviews for 2,4‐DB, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
title_sort | lack of confirmatory data following article 12 mrl reviews for 2,4‐db, iodosulfuron‐methyl, mesotrione, methoxyfenozide and pyraflufen‐ethyl |
topic | Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186194/ https://www.ncbi.nlm.nih.gov/pubmed/37200853 http://dx.doi.org/10.2903/j.efsa.2023.8013 |
work_keys_str_mv | AT lackofconfirmatorydatafollowingarticle12mrlreviewsfor24dbiodosulfuronmethylmesotrionemethoxyfenozideandpyraflufenethyl |